Epigallocatechin-3-gallate

OTHER3 trials

Sponsors

Cairo University, Shandong Cancer Hospital and Institute, Han Xi Zhao

Conditions

Chemotherapy-induced Peripheral NeuropathyDysphagia, EsophagealEpigallocatechin GallateEsophageal CancerNecrotic Pulp

Phase 1

EGCG for the Prevention and Treatment of TIPN

RecruitingNCT06524609

Han Xi ZhaoChemotherapy-induced Peripheral Neuropathy

Start: 2023-11-30End: 2025-01-30Target: 36Updated: 2024-07-29

Phase 2

A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer

RecruitingNCT06398405

Shandong Cancer Hospital and InstituteDysphagia, Esophageal, Epigallocatechin Gallate, Esophageal Cancer

Start: 2024-04-22End: 2026-05-22Target: 72Updated: 2024-05-03

Unknown Phase

Effect of Epigallocatechin-3-Gallate Solution as a Root Canal Irrigant on Post-Operative Pain Intensity and Bacterial Load Reduction in Necrotic Tooth

CompletedNCT05988788

Cairo UniversityNecrotic Pulp

Start: 2023-10-01End: 2024-07-30Updated: 2025-01-10